Becca Trombler, MSc
Senior CRC
Pediatrics
School of Medicine

Publications (3)

Top publication keywords:
MaleInfliximabHumansAdalimumabBiological ProductsChildProspective StudiesFemaleCrohn DiseaseDrug MonitoringWithholding TreatmentUnited StatesAdolescent

• The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in Children.
  The American journal of gastroenterology 2026 Constant BD, Feng Y, Huang J, Okraku-Mantey J, Adler J, Ali S, Barry J, Cruz R, Crawford EC, Dotson JL, Ewalt MK, Huang JS, Kachelries K, Kurowski JA, Minar P, Mitchel EB, Montminy TD, Morrow R, …
• Multicenter study of continuing ustekinumab after intravenous induction reactions in pediatric Crohn's disease.
  JPGN reports 2025 Samalik J, Singer A, Ali S, Anandakrishnan A, Baker MK, Creps J, Khorrami C, Maltz RM, Manning L, Moses J, Pasternak B, Patel PV, Singer DC, Suskind DL, Trombler B, Adler J, ImproveCareNow Pediatric …
• Characterization of Biologic Discontinuation Among Pediatric Patients With Crohn's Disease.
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024 Ali S, Pasternak B, Moses J, Suskind DL, Samson C, Kaplan J, Creps J, Manning L, Baker M, Singer D, Patel P, Trombler B, Anandakrishnan A, Khorrami C, Feldman M, McGoldrick M, Adler J